MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Silk Road Medical
Data Update From the VQI Registry
With Patric Liang, MD; Marc L. Schermerhorn, MD; Hanaa Dakour-Aridi, MD; Mahmoud B. Malas, MD, MHS, FACS; and Scott S. Berman, MD, MHA, RVT, FACS, DFSVS
Sponsored by Boston Scientific Corporation
An Inconvenient Truth? Optimization of Carotid Stenting Is Dependent on the Approach and Method of Embolic Protection
By Mahmoud B. Malas, MD, MHS, FACS, RPVI, and Mohammed Hamouda, MD
Study Compares Surgical Bypass Versus Angioplasty and Stent Treatment in SFA
January 7, 2014—In the Journal of Vascular Surgery, Mahmoud B. Malas, MD, et al published findings from a study conducted to evaluate contemporary outcomes of femoropopliteal bypass compared with angioplasty and stent treatment in patients with symptomatic peripheral arterial disease in terms of patency and reintervention rates (2014;59:129–135).
PYTHAGORAS United States Trial Evaluates Lombard's Aorfix Endograft
August 28, 2015—Findings from the PYTHAGORAS United States clinical trial of the Aorfix endograft (Lombard Medical) were published by Mahmoud B. Malas, MD, et al online ahead of print in the Journal of Vascular Surgery (JVS).
Favorable Outcomes for TCAR Versus CEA Presented at Vascular Annual Meeting
June 13, 2019—Silk Road Medical, Inc. announced real-world data from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project evaluating the treatment of patients with carotid artery disease at risk for stroke.
Outcomes Reported From TCAR Surveillance Project Studying TCAR Versus CEA
September 21, 2020—Silk Road Medical, Inc. announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR with carotid endarterectomy (CEA) were published online ahead of print in Annals of Surgery by Mahmoud B. Malas, MD, et al.
Cost-Effectiveness of TCAR Versus CEA Evaluated in Simulation Model
December 30, 2021—A cost-effectiveness analysis comparing transcarotid artery revascularization (TCAR) with carotid endarterectomy (CEA) for carotid artery stenosis found that although 5-year costs for TCAR were greater, TCAR afforded greater quality-adjusted life years (QALYs) than CEA.
CREST Substudy Finds Balloon Angioplasty After Carotid Stenting Reduces Restenosis Risk
May 9, 2013—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of a CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) substudy at the SCAI 2013 scientific sessions in Orlando, Florida.
Long-Term PYTHAGORAS Data Presented for Lombard Medical's Aorfix Bifurcated Stent Graft
June 13, 2016—Lombard Medical, Inc. announced the presentation of findings from PYTHAGORAS, the Prospective Aneurysm Trial: High Angle Aorfix Bifurcated Stent Graft, at the Society for Vascular Surgery’s 2016 Vascular Annual Meeting, which was held June 8–11 in National Harbor, Maryland.
ROADSTER-2 Demonstrates Positive Patient Outcomes With Silk Road's Enroute TCAR Systems
June 15, 2019—Silk Road Medical, Inc. announced positive final results for the company’s ROADSTER-2 postmarketing study evaluating real-world use of the Enroute neuroprotection and stent systems in transcarotid artery revascularization (TCAR) procedures.
Medicare Reimbursement for TransCarotid Arterial Revascularization (TCAR)
How are hospitals and physicians reimbursed by Medicare for TCAR procedures?
By Alex Au-Yeung
Renal Artery Fibromuscular Dysplasia Update
Diagnosis and management of this serious but underdiagnosed disease.
By Joe F. Lau, MD, PhD; Robert A. Lookstein, MD; and Jeffrey W. Olin, DO
Endovascular Management of Refractory Type I Endoleaks
Tools and techniques to allow tailored endoleak resolution and ultimately decrease aneurysm rupture rates.
By John Moriarty, MD, and Mahmood K. Razavi, MD, FSIR, FSVM
